heptaminol has been researched along with Shock, Septic in 1 studies
Heptaminol: An amino alcohol that has been used as a myocardial stimulant and vasodilator and to relieve bronchospasm. Its most common therapeutic use is in orthostatic hypotension. The mechanism of heptaminol's therapeutic actions is not well understood although it has been suggested to affect catecholamine release or calcium metabolism.
Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahloul, M | 1 |
| Chaari, A | 1 |
| Ben Mbarek, MN | 1 |
| Kallel, H | 1 |
| Bouaziz, M | 1 |
1 trial available for heptaminol and Shock, Septic
| Article | Year |
|---|---|
Use of heptaminol hydrochloride for catecholamine weaning in septic shock.
Topics: Adult; Aged; Dopamine; Female; Heptaminol; Hospital Mortality; Humans; Intensive Care Units; Male; M | 2012 |